FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Rubio criticizes media for demanding comment on Guilfoyle report: ‘It’s not the gospel’

‘Demon,’ ‘Bigot,’ ‘Satan Spawn’: Duchess Meghan’s Fans Rabidly Attack Priest for Offering up $8 Version of Her $150 Advent Calendar

‘Cornell 7’ Figure Fights Back Against ‘Improper’ Appointment of Letitia James with Court Move

Ken Paxton touts ‘missing Talarico’ flyers across Texas

‘Annie Trannie Andrews’ and ‘Mohammed el Sayed’: Trump goes scorched-earth on Democrats. Will it backfire?

Nicolas Maduro and wife Cilia Flores face new charge of conspiracy to torture Americans

Dem House hopeful alleges she was brutally attacked during 2 am campaign errand

Fox News President Issues Defiant Response to Trump’s Criticism: ‘It’s What We Do’

Andrews says she doesn’t support gender surgeries for minors after previously advocating against a ban

Russia denies another plague case as WHO presses for more information

Taxpayer-funded autism giant faces scrutiny over abuse cases and billing as Trump targets healthcare fraud

Rally Crowd Chants ‘Where Is James Talarico’ as Senate Candidate Disappears from Campaign Trail for 11 Days

Letitia James’ underdog rival turns AG’s own playbook against her with scathing 52-count campaign ‘indictment’

Hillary Clinton issues endorsement in US midterm elections

Ithaca council halts Cornell event permits amid scrutiny over handling of rape allegations

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”